Leases (Tables)

12 Months Ended

Dec. 31, 2019

The following table presents the lease balances within the consolidated balance sheet and other supplemental information related to our leases as of December 31, 2019:



Operating Leases:
Operating lease right-of-use assets, net	$	84

Accrued expenses, other	$	19
Other liabilities	67
Total operating lease liabilities	$	86

Finance Leases:
Property and equipment, net	$	2

Current maturities of long-term debt and other borrowings	$	1
Long-term debt and other borrowings, net	—
Total finance lease liabilities	$	1

Weighted-average remaining lease term:
Operating leases	6.8 years
Finance leases	2.4 years
Weighted-average discount rate:
Operating leases	3.5		%
Finance leases	8.1		%

Supplemental Cash Flow Information

Supplemental cash flow information related to leases for the year ended was as follows:



	December 31, 2019
Cash paid for amounts included in the measurement of operating lease liabilities	$	25
Right-of-use assets obtained in exchange for new operating lease liabilities	$	104
Right-of-use assets obtained in exchange for new finance lease liabilities	$	1

Operating Lease Maturities

The following table presents the maturity of our lease liabilities as of December 31, 2019:



	Operating Leases			Finance Leases
2020	$	22		$	1
2021	18			—
2022	13			—
2023	9			—
2024	8			—
Thereafter	28			—
Total minimum lease payments	98			1
Less: amount representing interest	(12		)	—
Present value of net minimum lease payments	86			1
Less: current portion of lease obligations	(19		)	(1		)
Long-term lease obligations	$	67		$	—

Additional Operating Leases Not Yet Commenced

As of December 31, 2019, we had additional operating leases that have not yet commenced which included the following:



Description	Commencing	Lease Term	Total Future Lease Payments
Compounding pharmacy and offices	January 2020	14 years	$	25
Compounding pharmacy	November 2020	20 years	28
New corporate headquarters	October 2021	20 years	78
Total			$	131